Related references
Note: Only part of the references are listed.Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies
Sanjib Das et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Eg5 targeting agents: From new anti-mitotic based inhibitor discovery to cancer therapy and resistance
Isabel Garcia-Saez et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Cell death in head and neck cancer pathogenesis and treatment
Martina Raudenska et al.
CELL DEATH & DISEASE (2021)
Future prospects for mitosis-targeted antitumor therapies
Alfonso Serrano-del Valle et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy
Goretti Duran et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer
Bruna Cândido Guido et al.
Oncotarget (2021)
Epigenetic Modifications in Head and Neck Cancer
Jadwiga Gazdzicka et al.
BIOCHEMICAL GENETICS (2020)
Invasion and metastasis: the elusive hallmark of cancer
Tomer Meirson et al.
ONCOGENE (2020)
Role of TGF-β in Skin Chronic Wounds: A Keratinocyte Perspective
Sergio Liarte et al.
CELLS (2020)
Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease
Larissa Di Villeneuve et al.
FRONTIERS IN ONCOLOGY (2020)
MicroRNA profile in the squamous cell carcinoma: prognostic and diagnostic roles
Soudeh Ghafouri-Fard et al.
HELIYON (2020)
Addition of tumour infiltration depth and extranodal extension improves the prognostic value of the pathological TNM classification for early-stage oral squamous cell carcinoma
Koos Boeve et al.
HISTOPATHOLOGY (2019)
Susceptibility of Multiple Primary Cancers in Patients With Head and Neck Cancer: Nature or Nurture?
Wei-long Zhang et al.
FRONTIERS IN ONCOLOGY (2019)
The kinesin Eg5 inhibitor K858 induces apoptosis and reverses the malignant invasive phenotype in human glioblastoma cells
Ludovica Taglieri et al.
INVESTIGATIONAL NEW DRUGS (2018)
High Eg5 expression predicts poor prognosis in breast cancer
Qin Jin et al.
ONCOTARGET (2017)
The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells
Francesca De Iuliis et al.
INVESTIGATIONAL NEW DRUGS (2016)
The prognostic role of Eg5 expression in laryngeal squamous cell carcinoma
Meiping Lu et al.
PATHOLOGY (2016)
Synthesis and pharmacological screening of a large library of 1,3,4-thiadiazolines as innovative therapeutic tools for the treatment of prostate cancer and melanoma
Celeste De Monte et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma
Monica Venere et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Knockdown of kinesin KIF11 abrogates directed migration in response to epidermal growth factor-mediated chemotaxis
Fang Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Prime movers: the mechanochemistry of mitotic kinesins
Robert A. Cross et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents
Hala Bakr El-Nassan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5
Prisca Exertier et al.
ONCOTARGET (2013)
Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5
Xiao-dong Sun et al.
ACTA PHARMACOLOGICA SINICA (2011)
The molecular biology of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2011)
EMT, the cytoskeleton, and cancer cell invasion
Mahmut Yilmaz et al.
CANCER AND METASTASIS REVIEWS (2009)
K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells
Ryuichiro Nakai et al.
CANCER RESEARCH (2009)
Overexpression of Eg5 causes genomic instability and tumor formation in mice
Andrew Castillo et al.
CANCER RESEARCH (2007)
Regulation and targeting of Eg5, a mitotic motor protein in blast crisis CML - Overcoming Imatinib resistance
Bing Z. Carter et al.
CELL CYCLE (2006)
Synthesis and biological evaluation of novel Eg5 inhibitors
V Sarli et al.
CHEMBIOCHEM (2005)
Multiple head and neck tumors frequently originate from a single preneoplastic lesion
MP Tabor et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Share Paper
